fda glp-1 warning news november 2025 Societies take stand against off-brand GLP-1s over safety concerns FDA Removes Black Box Warning

, & Reddy, P

Available online at: 7

An Eli Lilly spokesperson noted that the federal court presiding over these claims ruled last summer that any plaintiff claiming to have had drug-induced gastroparesis must have had a gastric emptying study properly performed at the time of diagnosis, confirming the diagnosis, and it recognized that its ruling meant some plaintiffs will be unable to prove that they suffered from gastroparesis. Lilly appreciates the Courts careful consideration of this and other threshold issues, and we will continue to defend against these claims in court. The first "bellwether test trials are not expected until 2027, plaintiffs attorneys said

For semaglutide doses, the volume loss from dead space at starting doses is proportionally larger, making low dead space syringes especially worthwhile early in the protocol

Its unclear what kinds of activity are best at boosting GLP-1, but high-intensity exercises such as running may be particularly beneficial